Skip to content

High rate of HCV reinfection after treatment of acute infection in Amsterdam gay men

Adverse effects of ART use in pregnancy: prematurity continues to raise concerns

Is treatment really reducing infections?

At least one in six patients maintains a viral load over one hundred thousand

Long-term HIV infection and poor inflammation control, not treatment, predicts risk of atherosclerosis

Optimising infant HIV treatment in resource-limited settings: when can nevirapine be used?

Six months of nevirapine prophylaxis for breastfeeding infants reduces transmission by 76% if mother not on ART

Partners study expands our knowledge of HIV transmission risk

Modellers examine the cost-effectiveness of PrEP in Africa

Rochelle Walensky of Harvard Medical School. Photo by Gus Cairns / aidsmap.com